Clinical significance of 14-3-3 zeta in human esophageal cancer

International Journal of Biological Markers

Volumn 23, Issue 4, 2008, Pages 231-237

  Bajpai, U ^a   Sharma, R ^b   Kausar, T ^c   Dattagupta, S ^c   Chattopadhayay, T K ^c   Ralhan, Ranju ^c  

^a UNIVERSITY OF DELHI   (India)

^b GURU GOBIND SINGH INDRAPRASTHA UNIVERSITY   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

14 3 3 zeta; Diagnostic marker; Dysplasia; Esophageal squamaous cell carcinoma (ESCC); Hyperplasia

Indexed keywords

BINDING PROTEIN; PROTEIN 14 3 3 ZETA; UNCLASSIFIED DRUG; MESSENGER RNA; PROTEIN 14 3 3; TUMOR MARKER;

ADULT; ARTICLE; CARCINOGENESIS; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DIFFERENTIAL DISPLAY; DYSPLASIA; ENDOSCOPIC BIOPSY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; FEMALE; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; ESOPHAGUS; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

14-3-3 PROTEINS; ADULT; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; IMMUNOBLOTTING; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 65349086261     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2009.2112     Document Type: Article

References (37)

1. Aitken A. 14-3-3 proteins: A historic overview. Semin Cancer Biol 2006;16: 162-72.
2. Shikano S, Coblitz B, Wu M, Li M. 14-3-3 proteins: regulation of endoplasmic reticulum localization and surface expression of membrane proteins. Trends Cell Biol 2006; 16: 370-5.
3. Rubio MP, Geraghty KM, Wong BHC, Wood NT, Campwell DG, Morrice N. 14-3-3 affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. Biochem J 2004; 379: 395-408.
4. Satoh J, Nanri Y, Yamamura T. Rapid identification of 14-3-3 binding proteins by protein microarray analysis. J Neurosci Methods 2006; 152: 278-88.
5. Hermeking H. 14-3-3 proteins and cancer biology. Semin Cancer Biol 2006; 16: 161.
6. Zannis-Hadjopoulos M, Yahyaoui W, Callejo M. 14-3-3 cruciform-binding proteins as regulators of eukaryotic DNA replication. Trends Biochem Sci 2008; 33: 44-50.
7. Woods YL, Rena G. Effect of multiple phosphorylation events on the transcription factors FKHR, FKHRL 1 and AFX. Biochem Soc Trans 2002; 30: 391-6.
8. Mackintosh C. Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem J 2004; 381: 329-42.
9. Simooka H, Oyama T, Sano T, Horiguchi J, Nakajima T. Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis. Pathol Int 2004; 54: 595-602.
10. Osada H, Tatematsu Y, Yatabe Y, et al. Frequent and histological type-specific inactivation of 14-3-3 sigma in human lung cancers. Oncogene 2002; 21: 2418-24.
11. Cheng L, Pan CX, Zhang JT, et al. Loss of 14-3-3 sigma in prostate cancer and its precursors. Clin Cancer Res 2004; 10: 3064-8.
12. Akahira J, Sugihashi Y, Suzuki T, et al. Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation. Clin Cancer Res 2004; 10: 2687-93.
13. Qi W, Liu X, Qiao D, Martinez JD. Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer 2005; 113: 359-63.
14. Tzivion G, Gupta VS, Kaplun L, Balan V: 14-3-3 proteins as potential oncogenes. Semin Cancer Biol 2006; 16: 203-13.
15. Han L, Wong D, Dhaka A, et al. Protein binding and signaling properties of RIN1 suggest a unique effector function. Proc Natl Acad Sci USA 1997; 94: 4954-9.
16. Birkenfeld J, Betz H, Roth D. Identification of cofilin and LIM-domain-containing protein kinase 1 as novel interaction partners of 14-3-3 zeta. Biochem J 2003; 369: 45-54.
17. Tian Q, Feetham MC, Tao WA, et al. Proteomic analysis identifies that 14-3-3ζ interacts with β-catenin and facilitates its activation by Akt. Proc Natl Acad Sci USA 2004; 101: 15370-5.
18. Oksvold MP, Huitfeldt HS, Langdon WY. Identification of 14-3-3 zeta as an EGF receptor interacting protein. FEBS Lett 2004; 569: 207-10.
19. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005; 55: 74-108.
20. Hermeking H. The 14-3-3 cancer connection. Nat Rev Cancer 2003; 3: 931-41.
21. Sharma R, Samantaray S, Shukla NK, Ralhan R. Transcriptional gene expression profile of human esophageal squamous cell carcinoma. Genomics 2003; 81: 481-8.
22. Krasna MJ, Wolfer RS. Esophageal carcinoma: diagnosis, evaluation and staging. In: Aisner J, Arriagada R, Green MR, Martini N, Perry MC, eds. Comprehensive textbook of thoracic oncology. Baltimore, MD: Williams and Wilkins, 1996; 563-84.
23. Sobin LH, Flemming ID. TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and The American Joint Committee on Cancer. Cancer 1997; 80: 1803-4.
24. Mathew R, Arora S, Khanna R, Mathur M, Shukla NK, Ralhan R. Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer. Eur J Cancer 2002; 38: 832-41.
25. Van Hermert MJ, Niemantsverdriet M, Schmidt T, Backendorf C, Spaink HP. Isoform-specific differences in rapid nucleocytoplasmic shuttling cause distinct subcellular distributions of 14-3-3 and 14-3-3. J Cell Sci 2004; 117: 1411-20.
26. Soni S, Mathur M, Shukla NK, Deo SV, Ralhan R. Stromelysin-3 expression is an early event in human oral tumorigenesis. Int J Cancer 2003; 107: 309-16.
27. Takihara Y, Matsuda Y, Hara J. Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation. Carcinogenesis 2000; 21: 2073-7.
28. Martin D, Brown-Luedi M, Chiquet-Ehrismann R. Tenascin-C signalling through induction of 14-3-3 tau. J Cell Biol 2003; 160: 171-5.
29. Jang JS, Cho HY, Lee YJ, Ha WS, Kim HW. The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res 2004; 14: 491-9.
30. Masters SC, Subramanian RR, Truong A, Yang H, Zhang FH, Fu H. Survival-promoting functions of 14-3-3 proteins. Biochem Soc Trans 2002; 30: 360-5.
31. Grozinger CM, Schreiber SL. Regulation of histone deacetylase 4 & 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natl Acad Sci USA 2000; 97: 7835-40.
32. Seimiya H, Sawada H, Muramatsu Y, et al. Involvement of 14-3-3 proteins in nuclear localization of telomerase. EMBO J 2000; 19: 2652-61.
33. Tang SJ, Suen TC, McInnes RR, Buchwald M. Association of the TLX-2 homeodomain and 14-3-3 zeta signalling proteins. J Biol Chem 1998; 273: 25356-63.
34. Zannis-Hadjopoulos M, Novac O, Alvarez D, Price GB. 14-3-3s are DNA-replication proteins. Biochem Soc Trans 2002; 30: 397-401.
35. Alvarez D, Novac O, Callejo M, Ruiz MT, Price GB, Zannis-Hadjopoulos M. 14-3-3 sigma is a cruciform DNA binding protein and associates in vivo with origins of DNA replication. J Cell Biochem 2002; 87: 194-207.
36. Matta A, DeSouza LV, Shukla NK, Gupta SD, Ralhan R, Siu KW. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res 2008; 7: 2078-87.
37. Qi W, Martinez JD. Reduction of 14-3-3 proteins correlates with increased sensitivity to killing of human lung cancer cells by ionizing radiation. Radiat Res 2003; 60: 217-23.